Minoxidil 10% Azelaic Acid 2% spray

From: £35.00
Or £31.50 / month

Minoxidil 10% / Azelaic Acid 2% topical spray combines high-strength Minoxidil with Azelaic Acid for enhanced follicle stimulation and local DHT inhibition — without the need for Finasteride. Particularly suited to men who want effective topical treatment while avoiding the Finasteride side effect profile.

Available from PharmaBee via confidential online consultation with a UK-registered hair loss specialist.

Select a strength:
Save by Subscribing
Quantity
🕒
Discreet PackagingHigh Sucess RateNext Day Delivery

Additional information

Quantity

120ml, 180ml, 60ml

Overview

Content Written by:

Hanifa Tai
Role: Pharmacist & Content Writer
GPhC Number: 2074961
Content Published: 01/04/2026
Next Review: 01/04/2027

Medically Reviewed by:

Farzin Ghayedy
Role: Pharmacist
GPhC Number: 2218065
Select a strength:
Save by Subscribing
Quantity

Description

What is Minoxidil 10% / Azelaic Acid 2% Topical Spray?

This compounded topical spray combines Minoxidil at 10% — double the standard topical strength — with Azelaic Acid at 2%. It is an unlicensed formulation has off-label by our team. It is a useful option for men who want effective DHT inhibition and follicle stimulation without Finasteride.

How does it work?

Minoxidil works as a vasodilator, widening blood vessels in the scalp to increase oxygen and nutrient delivery to hair follicles. It prolongs the anagen (growth) phase and reduces the telogen (resting) phase of the hair cycle. Azelaic Acid inhibits 5-alpha reductase locally, reducing scalp DHT activity without the need for Finasteride. It also increases the action of catalase, reducing oxidative stress and damage to follicles. Together, these ingredients nourish and strengthen the scalp, promoting thicker and healthier hair growth.

Why choose this over Finasteride-containing products?

This formulation is particularly suited to men who are concerned about the side effect profile of Finasteride or Dutasteride, while still wanting to address DHT-driven hair loss through a topical approach.

How to use it

Apply to dry scalp in affected areas once daily. Part the hair, spray directly onto scalp, allow to dry fully before styling. Wash hands after use. Do not wash hair for at least 4 hours after application.

Who should not use this spray?

  • Women
  • Anyone under 18
  • People with sudden or patchy hair loss
  • People with scalp infection or broken skin
  • Anyone allergic to Minoxidil, Azelaic Acid, or their components

FAQ

Q: Why choose this spray over one with Finasteride?

A: This spray is a good option for men who want to address DHT at follicle level without using Finasteride. Azelaic Acid provides local 5-alpha reductase inhibition, reducing scalp DHT without systemic effects.

Q: Why is the Minoxidil concentration higher at 10%?

A: This higher-strength formulation (double the standard 5% topical concentration) is typically used when standard-strength Minoxidil has not provided sufficient response, or as a more intensive starting treatment.

Q: Is this a licensed medicine?

A: This is an unlicensed compounded medicine prescribed off-label by a UK-registered prescriber following clinical assessment.

Q: How long before I see results?

A: Stabilisation is typically seen within 3–4 months, with visible improvement at 4–6 months and maximum benefit at 9–12 months of daily use.

Q: What happens if I stop using it?

A: Stopping treatment will usually lead to a reversal of beneficial effects.

Side Effects

As an unlicensed formulation, the full side effect profile is still developing. The spray is generally well-tolerated with minimal side effects due to lower systemic absorption.

Common side effects:

  • Mild scalp irritation, redness, or dryness at the application site

Uncommon:

  • Headache or dizziness
  • Increased facial or body hair (if applied incorrectly)

Rare but serious:

  • Chest pain or severe dizziness
  • Severe allergic reaction
  • Difficulty breathing or severe swelling — Seek urgent medical attention.

Temporary shedding may occur during the first 2–8 weeks. Stop use and raise any concerns with your prescriber or GP. Report side effects via the MHRA Yellow Card Scheme: www.mhra.gov.uk/yellowcard